WO2024060825A1 - X-ray developing compound and preparation method therefor, and x-ray developing microsphere and preparation method therefor - Google Patents

X-ray developing compound and preparation method therefor, and x-ray developing microsphere and preparation method therefor Download PDF

Info

Publication number
WO2024060825A1
WO2024060825A1 PCT/CN2023/109266 CN2023109266W WO2024060825A1 WO 2024060825 A1 WO2024060825 A1 WO 2024060825A1 CN 2023109266 W CN2023109266 W CN 2023109266W WO 2024060825 A1 WO2024060825 A1 WO 2024060825A1
Authority
WO
WIPO (PCT)
Prior art keywords
microspheres
compound
preparation
developing
ray developing
Prior art date
Application number
PCT/CN2023/109266
Other languages
French (fr)
Chinese (zh)
Inventor
孙宏涛
李鑫
孙蓬
Original Assignee
科睿驰(深圳)医疗科技发展有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 科睿驰(深圳)医疗科技发展有限公司 filed Critical 科睿驰(深圳)医疗科技发展有限公司
Publication of WO2024060825A1 publication Critical patent/WO2024060825A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C08G65/2606Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
    • C08G65/2609Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups containing aliphatic hydroxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/36Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present application relates to the technical field of embolization visualized under X-rays, and in particular to an X-ray developing compound and its preparation method, X-ray developing microspheres and its preparation method.
  • Patent CN102781974B describes the use of iodobenzyl bromide or benzyl methanesulfonate to modify polyvinyl alcohol (PVA) microspheres under alkaline conditions to obtain a polyvinyl alcohol embolus with an iodobenzyl ether structure.
  • PVA polyvinyl alcohol
  • This embolus has X Radiographic development function.
  • this method consumes hydroxyl groups while developing and modifying, causing the modified PVA to become less hydrophilic.
  • Patent 114805644A describes grafting epichlorohydrin onto polyvinyl alcohol under alkaline catalyst conditions, introducing chlorine atoms into the polyvinyl alcohol to obtain activated polyvinyl alcohol; and then combining the activated polyvinyl alcohol with iodine Benzyl alcohol undergoes an etherification reaction to graft the iodobenzyl group onto polyvinyl alcohol, thereby obtaining an iodine-containing polyvinyl alcohol polymer.
  • the polymer is soluble in non-physiological solutions and insoluble under physiological conditions, and can be used as a liquid embolization material in medical treatment with stability and development effects.
  • the chemical structure of the developing base described in this method is -OCH 2 CH(OH)CH 2 OR, and R is an iodobenzyl group.
  • This method generates a hydroxyl group while developing and modifying, which can better maintain the hydrophilic properties of PVA.
  • developing and modifying requires a two-step reaction and the process is complicated.
  • active chloride ions are introduced into the process, and the biological safety of chlorinated hydrocarbons needs to be verified. The safety risks of this process are relatively high.
  • the purpose of the embodiments of the present application includes providing an X-ray developing compound and a preparation method thereof, X-ray developing microspheres and a preparation method thereof, based on a new type of developing compound, which can be combined with polyvinyl alcohol microspheres.
  • the ball reacts in one step, the process is safe, and polyvinyl alcohol microspheres with X-ray developing function are obtained, and their hydrophilicity is good.
  • embodiments of the present application provide an X-ray developing compound.
  • the structural formula of the X-ray developing compound is as follows:
  • n is an integer from 1 to 5.
  • an iodoaryl group and an epoxy group are connected through an ether bond to form an Vinyl alcohol microspheres have a developing function, and the prepared developing microspheres are relatively hydrophilic.
  • the structural formula of the X-ray developing compound is:
  • this application provides a method for preparing the above-mentioned X-ray developing compound, reaction formula 1:
  • the developing compound can be obtained through a one-step reaction between iodobenzyl alcohol compounds and 3-epoxypropane.
  • the reaction conditions are relatively mild and the preparation is relatively simple.
  • this application provides an X-ray developing microsphere.
  • the structural formula of the developing microsphere is as follows:
  • n is an integer from 1 to 5.
  • the hydrophilicity of the X-ray developing microspheres is relatively good.
  • the structural formula of the developing microspheres is as follows:
  • the present application provides a method for preparing X-ray developing microspheres, including: under the catalytic action of an organic acid or an organic base, the epoxy group of the above-mentioned X-ray developing compound is combined with at least one of the polyvinyl alcohol microspheres. Part of the hydroxyl group reacts to form an ether bond.
  • the preparation of X-ray developing microspheres can be relatively simple, and the polyvinyl alcohol microspheres can be given a developing function through a direct one-step reaction. At the same time, the obtained developing microspheres have good hydrophilicity.
  • the catalyst is an organic acid
  • the preparation method includes:
  • an organic acid is used as a catalyst to react in the next step at a lower temperature to modify the polyvinyl alcohol microspheres to obtain developing microspheres.
  • the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound to the organic acid is 1:(0.1-2).
  • the organic acid is at least one of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and trifluoroacetic acid;
  • the solvent is dimethyl sulfoxide, N,N-dimethyl At least one of methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.
  • the catalyst is an organic base
  • the preparation method includes:
  • the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound to the organic base is 1:(0.5-3).
  • the organic base is triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diaza At least one of heterobicyclo[2.2.2]octane;
  • the solvent is dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone of at least one.
  • Figure 1 is an optical picture of the wet bulb of polyvinyl alcohol raw material provided by the implementation team of this application;
  • Figure 2 is an optical picture of the developed microspheres provided in Example 1;
  • Figure 3 is an optical picture of the developed microspheres provided in Example 2.
  • Figure 4 is an optical picture of the developed microspheres provided in Example 3.
  • Figure 5 is an optical picture of the developed microspheres provided in Example 4.
  • Figure 6 is an optical picture of the developed microspheres provided in Example 5.
  • Figure 7 is an optical picture of the developed microspheres provided in Example 6;
  • Figure 8 is an optical picture of the developed microspheres provided in Example 7.
  • Figure 9 is an optical picture of the developed microspheres provided in Example 8.
  • FIG10 is an optical image of the developed microspheres provided in Example 9;
  • Figure 11 is an optical picture of the developed microspheres provided in Example 10.
  • Figure 12 is an optical picture of the developed microspheres provided in Example 11;
  • Figure 13 is an optical picture of the developed microspheres provided in Embodiment 12;
  • Figure 14 is an optical picture of the developed microspheres provided in Comparative Example 1;
  • Figure 15 is an optical picture of the developed microspheres provided in Comparative Example 2.
  • n is an integer from 1 to 5.
  • the function of I atoms is to develop under X-ray irradiation, and the number of I atoms can be 1, 2, 3, 4 or 5.
  • the number of substitutions of I atoms will not cause differences in the hydrophilicity and suspension properties of the developing microspheres after the developer is combined with the microspheres.
  • an iodoaryl group and an epoxy group are connected through an ether bond to form an Vinyl alcohol microspheres have a developing function, and the prepared developing microspheres are relatively hydrophilic.
  • the structural formula of the X-ray developing compound can be:
  • the structural formula of the X-ray imaging compound may also be:
  • Reaction Formula 1 is as follows:
  • compound II, compound III, tetrabutylammonium hydrogen sulfate (2-20 mol%) and tetrahydrofuran (THF) are mixed uniformly to form a solution; 40-60% (w/w) sodium hydroxide or/and potassium hydroxide solution is added at 0-5°C, react for 20-40 minutes, then warm to room temperature and react for 4-24 hours.
  • the structural formula of the X-ray developing microsphere is as follows:
  • n is an integer from 1 to 5.
  • the hydrophilicity of the X-ray developing microspheres is relatively good.
  • the structural formula of the developing microspheres can be:
  • the structural formula of the developing microspheres can also be:
  • the epoxy group of the above-mentioned X-ray developing compound is reacted with at least part of the hydroxyl groups on the polyvinyl alcohol microspheres to form an ether bond.
  • the preparation of X-ray developing microspheres can be relatively simple, and the polyvinyl alcohol microspheres can be given a developing function through a direct one-step reaction. At the same time, the obtained developing microspheres have good hydrophilicity.
  • polyvinyl alcohol microspheres The preparation method of polyvinyl alcohol microspheres is as follows: polyvinyl alcohol and N-(2,2-dimethoxyethyl)-2-acrylamide are subjected to an acid-catalyzed reaction to obtain a macromolecular polyvinyl alcohol monomer grafted with N-(2,2-dimethoxyethyl)-2-acrylamide; the macromolecular polyvinyl alcohol monomer is prepared with a water-soluble monomer with a sulfonic acid group, an initiator and water to form an aqueous phase, and the aqueous phase is added to the oil phase under mechanical stirring to form an oil-in-water reverse suspension polymerization system; the reverse suspension polymerization system is heated to a reaction temperature, and a catalyst is added to carry out a suspension polymerization reaction; polyvinyl alcohol microspheres are obtained by reaction, and polyvinyl alcohol microsphere dry balls are obtained after purification and drying processes.
  • the catalyst is an organic acid
  • the preparation method comprises:
  • dry polyvinyl alcohol microspheres, X-ray developing compound I and solvent are mixed and heated to swell. After swelling, organic acid is added and reacted at 40-90°C for 24-48 hours. After the reaction, clean and remove impurities.
  • the mass ratio of the X-ray developing compound and the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound and the organic acid is 1:(0.1-2).
  • the organic acid is at least one of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and trifluoroacetic acid;
  • the solvent is dimethyl sulfoxide (DMSO) or N,N-dimethylformamide (DMF).
  • DMSO dimethyl sulfoxide
  • DMF N,N-dimethylformamide
  • NMP N,N-dimethylacetamide and N-methylpyrrolidone
  • the reaction temperature is 40°C, 50°C, 60°C, 70°C, 80°C or 90°C; the reaction time is 24h, 28h, 32h, 36h, 40h, 44h or 48h; the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is 1.5:1, 2:1, 2.5:1 or 3:1; the mass ratio of the X-ray developing compound to the organic acid is 1:0.1, 1:0.5, 1:1, 1:1.5 or 1:2.
  • the catalyst is an organic base
  • the preparation method includes:
  • polyvinyl alcohol microsphere dry balls, X-ray imaging compound I and solvent are mixed and heated to swell, and then an organic base is added after swelling, and the mixture is reacted at 60-120° C. for 24-48 hours. After the reaction, the mixture is washed and impurities are removed.
  • the mass ratio of the X-ray developing compound and the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound and the organic base is 1:(0.5-3).
  • the organic bases are triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, and 1,4-diazabicyclo[2.2.2]octane At least one of alkane; the solvent is at least one of dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
  • the reaction temperature is 60°C, 70°C, 80°C, 90°C, 100°C, 110°C or 120°C;
  • the reaction time is 24h, 28h, 32h, 36h, 40h, 44h or 48h;
  • the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is 1.5:1, 2:1, 2.5:1 or 3:1;
  • the mass ratio of the X-ray developing compound to the organic base is 1:0.5, 1:1, 1:1.5, 1:2, 1:2.5 or 1:3.
  • X-ray developing microspheres are prepared through a one-step reaction, and the developing microspheres have good hydrophilicity.
  • compound II-1 (20.6mmol, 10g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-mouth reaction bottle. , stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • the liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-1 (9.5 g, 85%), which is a light yellow viscous oily liquid (purity 98%). .
  • the obtained target product I-1 was characterized by HPLC (high performance liquid chromatography), LCMS (liquid phase mass spectrometry) and 1 H-NMR (proton nuclear magnetic spectrum). Methods as below:
  • HPLC The test instrument is an Agilent 1260 high-performance liquid chromatograph; the chromatographic column is an octadecyl-bonded silica gel column; the mobile phase is 0.1% phosphoric acid aqueous solution and methanol; the detector is a VWD detector; take about 0.1mg of the sample and put it on the sample In the bottle, add DMSO to dissolve and directly inject the sample for testing; determine the product purity based on the integrated area.
  • LCMS The test instrument is Agilent 1260-6125 high performance liquid chromatography mass spectrometer; the chromatographic column is an octadecyl bonded silica gel column; the mobile phase is 0.1% formic acid aqueous solution and methanol; the detector is a mass spectrometer detector; take 0.1 Put about mg sample into the sample bottle, add DMSO to dissolve it and directly inject the sample for detection to identify the main ion peaks.
  • the test instrument is a Bruker 400M nuclear magnetic tester; the probe used is a normal temperature hydrogen spectrometer probe; add 20-30mg of the sample into the nuclear magnetic tube, add 0.3-0.5mL of deuterated chloroform to dissolve and test.
  • compound II-2 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • the liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-2 (5.38 g, 90%) as a light yellow oily liquid (purity 98%).
  • compound II-3 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • target compound I-3 (5.44 g, 91%) as a light yellow oily liquid (purity 98%).
  • compound II-4 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • the liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-4 (5.68 g, 95%) as a light yellow oily liquid (purity 98%).
  • compound II-5 (20.6mmol, 7.4g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to a single-mouth reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • the liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-5 (5.44 g, 91%) as a light yellow oily liquid (purity 98%).
  • compound II-6 (20.6mmol, 10g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to a single-mouth reaction bottle. , stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution.
  • the liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-6 (9.7g, 87%), which was a light yellow viscous oily liquid (purity 98%). .
  • the speed was set to 400 rpm, and the aqueous phase was added dropwise to the oil phase; after the addition was completed, the temperature was raised to 55°C, 2.2 mL of tetramethylethylenediamine was added, and the reaction was continued for 8 hours. After a series of purifications and drying, the raw material dry ball was obtained.
  • the obtained activated polyvinyl alcohol was dissolved in 50 ml of anhydrous NMP.
  • the reaction mixture was stirred at 130°C for 5 minutes; then the temperature was allowed to drop to 50°C.
  • 55 g of 2,3,5-triiodobenzyl alcohol (0.113 mol) were added and the reaction mixture was stirred for 10 minutes.
  • 0.05 g of ground and dried NaOH was added over 10 minutes. After 4 hours, cool to room temperature.
  • the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres.
  • Figure 1 is an optical picture of the polyvinyl alcohol wet ball provided by the implementation group of this application
  • Figure 2 is an optical picture of the developed microsphere provided in Example 1
  • Figure 3 is an optical picture of the developed microsphere provided in Example 2
  • Figure 4 Figure 5 is an optical picture of the developed microspheres provided in Example 3
  • Figure 5 is an optical picture of the developed microspheres provided in Embodiment 4
  • Figure 6 is an optical picture of the developed microspheres provided in Embodiment 5
  • Figure 7 is provided in Embodiment 6
  • Figure 8 is an optical picture of the developed microspheres provided in Embodiment 7
  • Figure 9 is an optical picture of the developed microspheres provided in Embodiment 8
  • Figure 10 is an optical picture of the developed microspheres provided in Embodiment 9
  • Figure 11 is an optical picture of the developed microspheres provided in Embodiment 10
  • Figure 12 is an optical picture of the developed microspheres provided in Embodiment 11
  • Figure 13 is an
  • Figure 14 is an optical picture of the developed microspheres provided in Comparative Example 1. It can be seen from Figure 14 that the microspheres provided in Comparative Example 1 expanded in volume and were destroyed.
  • Figure 15 is an optical picture of the developed microspheres provided in Comparative Example 2. As can be seen from Figure 15, the microspheres provided in Comparative Example 2 have poor morphology and a large number of adhesions.
  • the absorption solution is: 10 mL 5 g/L sodium hydroxide and 10 mL 1% vitamin C. Rapidly oxygenate for 1 minute, and cover the bottle with a watch glass. mouth, let it stand for 10 minutes, ignite the tail of the filter paper wrapped with the sample, quickly insert the stopper into the combustion bottle, press the stopper tightly, and seal the bottle mouth with a small amount of water. After burning (there should be no gray or black fragments or particles, if after burning There should be no gray or black fragments or particles left, which means the test sample is not completely burned. In this case, resample and burn).
  • C is the concentration of silver nitrate, mol/L
  • V is the consumption volume of silver nitrate, mL
  • M is the sample mass, mg
  • M (wet bulb): is the wet bulb mass, mg;
  • V (wet bulb): is the wet bulb volume, mL;
  • 127 is the relative molecular mass of iodine.
  • wet bulb iodine content (microsphere dry weight ⁇ dry bulb iodine content)/wet bulb volume
  • HU value test method The developing microspheres of each example were subjected to Micro CT testing, and the radiopacity of the developing microsphere samples prepared according to the above method was evaluated. Beads were suspended in 0.5% agarose gel in Nunc cryovial vials, and the micro-CT imaging system scanner equipped with a tungsten anode was used to develop micro-computed tomography (micro-CT imaging system). Radiopacity was tested. The images were then segmented to separate the polymer from the pore structure in order to report the polymer radiation density. The radiation density in HU was then calculated using water standards obtained on the same day.
  • the X-ray developing compounds provided in this application can all make polyvinyl alcohol microspheres have a developing function through a one-step reaction. And by using organic acids as catalysts, the developed microspheres obtained have higher iodine content, higher HU value, and stronger developing ability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to an X-ray developing compound and a preparation method therefor, and an X-ray developing microsphere and a preparation method therefor, and belongs to the technical field of embolization visualization under X-rays. The X-ray developing compound has a structural formula shown as follows: (I), wherein n is an integer from 1 to 5. According to the developing compound, an iodo aryl group and an epoxy group are connected by means of an ether bond to form the X-ray developing compound. The epoxy group in the developing compound is easy to subject to a one-step reaction with a hydroxyl group in a polyvinyl alcohol microsphere, such that the polyvinyl alcohol microsphere has a developing function, and the prepared developing microsphere has good hydrophilicity.

Description

X射线显影化合物及其制备方法、X射线显影微球及其制备方法X-ray developing compounds and preparation methods thereof, X-ray developing microspheres and preparation methods thereof
相关申请的交叉引用Cross-references to related applications
本申请要求于2022年09月22日提交中国专利局的申请号为202211159438.5、名称为“X射线显影化合物及其制备方法、X射线显影微球及其制备方法”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application requires the priority of the Chinese patent application with application number 202211159438.5 and titled "X-ray developing compounds and preparation methods thereof, X-ray developing microspheres and preparation methods thereof" submitted to the China Patent Office on September 22, 2022. The entire contents of which are incorporated herein by reference.
技术领域Technical field
本申请涉及X射线下可视化的栓塞技术领域,且特别涉及一种X射线显影化合物及其制备方法、X射线显影微球及其制备方法。The present application relates to the technical field of embolization visualized under X-rays, and in particular to an X-ray developing compound and its preparation method, X-ray developing microspheres and its preparation method.
背景技术Background technique
自经导管动脉栓塞术(Transcatheter Arterial embolization,简称TAE)的概念提出40多年来,选择合适的栓塞材料是该技术发展关键的一环。由于碘原子对X射线的强吸收,含碘化合物,尤其是含碘有机化合物,可在X射线检测下人体内显影。因此,可以在栓塞材料上连接含碘的有机化合物,从而使栓塞材料具有X射线显影的功能。For more than 40 years since the concept of transcatheter arterial embolization (TAE) was proposed, selecting appropriate embolization materials is a key part of the development of this technology. Due to the strong absorption of X-rays by iodine atoms, iodine-containing compounds, especially iodine-containing organic compounds, can be visualized in the human body under X-ray detection. Therefore, an iodine-containing organic compound can be connected to the embolic material, so that the embolic material has the function of X-ray development.
专利CN102781974B描述了采用碘代苄溴或甲磺酸苄酯在碱性条件下修饰聚乙烯醇(PVA)微球,得到具有碘代苄基醚结构的聚乙烯醇栓塞物,此栓塞物具有X射线下显影功能。但是此方法在显影修饰的同时消耗羟基,致使修饰后的PVA亲水性变差。Patent CN102781974B describes the use of iodobenzyl bromide or benzyl methanesulfonate to modify polyvinyl alcohol (PVA) microspheres under alkaline conditions to obtain a polyvinyl alcohol embolus with an iodobenzyl ether structure. This embolus has X Radiographic development function. However, this method consumes hydroxyl groups while developing and modifying, causing the modified PVA to become less hydrophilic.
专利114805644A描述了在碱性催化剂条件下将环氧氯丙烷接枝到聚乙烯醇上,在聚乙烯醇上引入了氯原子,得到活化的聚乙烯醇;再由活化的聚乙烯醇与碘代苄醇通过醚化反应,使得碘代苄基接枝到聚乙烯醇上,进而得到了含碘的聚乙烯醇聚合物。该聚合物在非生理溶液可溶且在生理条件下不溶,可用作医学治疗中液体栓塞材料,具有稳定性和显影效果。此方法所述显影测基的化学结构为-OCH2CH(OH)CH2OR,R为碘代苄基。此方法在显影修饰的同时生成一个羟基,可较好保持PVA的亲水性能,但是显影修饰需要两步反应,工艺复杂。此外,在工艺中引入活性的氯离子,氯代烃的生物安全性有待考证,此工艺的安全性风险较大。Patent 114805644A describes grafting epichlorohydrin onto polyvinyl alcohol under alkaline catalyst conditions, introducing chlorine atoms into the polyvinyl alcohol to obtain activated polyvinyl alcohol; and then combining the activated polyvinyl alcohol with iodine Benzyl alcohol undergoes an etherification reaction to graft the iodobenzyl group onto polyvinyl alcohol, thereby obtaining an iodine-containing polyvinyl alcohol polymer. The polymer is soluble in non-physiological solutions and insoluble under physiological conditions, and can be used as a liquid embolization material in medical treatment with stability and development effects. The chemical structure of the developing base described in this method is -OCH 2 CH(OH)CH 2 OR, and R is an iodobenzyl group. This method generates a hydroxyl group while developing and modifying, which can better maintain the hydrophilic properties of PVA. However, developing and modifying requires a two-step reaction and the process is complicated. In addition, active chloride ions are introduced into the process, and the biological safety of chlorinated hydrocarbons needs to be verified. The safety risks of this process are relatively high.
申请内容Application content
针对现有技术的不足,本申请实施例的目的包括提供一种X射线显影化合物及其制备方法、X射线显影微球及其制备方法,基于一类新的显影化合物,能够与聚乙烯醇微球一步反应,工艺安全性好,得到具有X射线显影功能的聚乙烯醇微球,且其亲水性较好。In view of the shortcomings of the existing technology, the purpose of the embodiments of the present application includes providing an X-ray developing compound and a preparation method thereof, X-ray developing microspheres and a preparation method thereof, based on a new type of developing compound, which can be combined with polyvinyl alcohol microspheres. The ball reacts in one step, the process is safe, and polyvinyl alcohol microspheres with X-ray developing function are obtained, and their hydrophilicity is good.
第一方面,本申请实施例提供了一种X射线显影化合物,X射线显影化合物的结构式如下:
In the first aspect, embodiments of the present application provide an X-ray developing compound. The structural formula of the X-ray developing compound is as follows:
其中,n是1-5的整数。Here, n is an integer from 1 to 5.
在上述技术方案中,通过醚键连接碘代芳基与环氧基,形成X射线显影化合物,该显影化合物中的环氧基容易与聚乙烯醇微球中的羟基发生一步反应,以使聚乙烯醇微球具有显影功能,并且制备的显影微球亲水性较好。In the above technical solution, an iodoaryl group and an epoxy group are connected through an ether bond to form an Vinyl alcohol microspheres have a developing function, and the prepared developing microspheres are relatively hydrophilic.
在本申请的部分实施例中,X射线显影化合物的结构式为:
In some embodiments of the present application, the structural formula of the X-ray developing compound is:
第二方面,本申请提供一种上述X射线显影化合物的制备方法,反应式一:
In a second aspect, this application provides a method for preparing the above-mentioned X-ray developing compound, reaction formula 1:
上述技术方案中,由碘代苄醇类化合物与3-环氧丙烷通过一步反应可以得到显影化合物,其反应条件较为温和,制备较为简单。In the above technical solution, the developing compound can be obtained through a one-step reaction between iodobenzyl alcohol compounds and 3-epoxypropane. The reaction conditions are relatively mild and the preparation is relatively simple.
第三方面,本申请提供一种X射线显影微球,显影微球的结构式如下:
In a third aspect, this application provides an X-ray developing microsphere. The structural formula of the developing microsphere is as follows:
其中,n是1-5的整数,通过控制交联反应条件和时间可以得到m值不同的X射线显影微球,其中m是大于1的正整数。Among them, n is an integer from 1 to 5. By controlling the cross-linking reaction conditions and time, X-ray developing microspheres with different m values can be obtained, where m is a positive integer greater than 1.
在上述技术方案中,该X射线显影微球的亲水性较好。In the above technical solution, the hydrophilicity of the X-ray developing microspheres is relatively good.
在本申请的部分实施例中,显影微球的结构式如下:
In some embodiments of this application, the structural formula of the developing microspheres is as follows:
第四方面,本申请提供一种X射线显影微球的制备方法,包括:在有机酸或有机碱的催化作用下,使上述X射线显影化合物的环氧基与聚乙烯醇微球上的至少部分羟基反应,以形成醚键结合。In a fourth aspect, the present application provides a method for preparing X-ray developing microspheres, including: under the catalytic action of an organic acid or an organic base, the epoxy group of the above-mentioned X-ray developing compound is combined with at least one of the polyvinyl alcohol microspheres. Part of the hydroxyl group reacts to form an ether bond.
在上述技术方案中,可以使X射线显影微球的制备较为简单,直接一步反应就可以使聚乙烯醇微球具有显影功能,同时,得到的显影微球的亲水性较好。In the above technical solution, the preparation of X-ray developing microspheres can be relatively simple, and the polyvinyl alcohol microspheres can be given a developing function through a direct one-step reaction. At the same time, the obtained developing microspheres have good hydrophilicity.
在本申请的部分实施例中,催化剂为有机酸,制备方法包括:In some embodiments of this application, the catalyst is an organic acid, and the preparation method includes:
反应式二:
Reaction 2:
在上述条件下,以有机酸作为催化剂,在温度较低的情况下一步反应,对聚乙烯醇微球进行修饰,以得到显影微球。Under the above conditions, an organic acid is used as a catalyst to react in the next step at a lower temperature to modify the polyvinyl alcohol microspheres to obtain developing microspheres.
在本申请的部分实施例中,X射线显影化合物与聚乙烯醇微球的质量比为(1.5-3):1;X射线显影化合物与有机酸的质量比为1:(0.1-2)。In some embodiments of the present application, the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound to the organic acid is 1:(0.1-2).
在本申请的部分实施例中,有机酸为甲磺酸、三氟甲磺酸、对甲苯磺酸、三氟乙酸中的至少一种;溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的至少一种。In some embodiments of the present application, the organic acid is at least one of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and trifluoroacetic acid; the solvent is dimethyl sulfoxide, N,N-dimethyl At least one of methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.
在本申请的部分实施例中,催化剂为有机碱,所述制备方法包括:In some embodiments of the present application, the catalyst is an organic base, and the preparation method includes:
反应式三:
Reaction three:
在本申请的部分实施例中,X射线显影化合物与聚乙烯醇微球的质量比为(1.5-3):1;X射线显影化合物与有机碱的质量比为1:(0.5-3)。In some embodiments of the present application, the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound to the organic base is 1:(0.5-3).
在本申请的部分实施例中,有机碱为三乙胺、二异丙基乙胺、1,8-二氮杂双环[5.4.0]十一碳-7-烯、1,4-二氮杂二环[2.2.2]辛烷中的至少一种;溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的至少一种。In some embodiments of this application, the organic base is triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diaza At least one of heterobicyclo[2.2.2]octane; the solvent is dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone of at least one.
附图说明Description of drawings
为了更清楚地说明本申请实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本申请的某些实施例,因此不应被看作是对范围的限定。In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required to be used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of the present application and therefore do not should be viewed as a limitation of scope.
图1为本申请实施组提供的聚乙烯醇原料湿球的光学图片;Figure 1 is an optical picture of the wet bulb of polyvinyl alcohol raw material provided by the implementation team of this application;
图2为实施例一提供的显影微球的光学图片;Figure 2 is an optical picture of the developed microspheres provided in Example 1;
图3为实施例二提供的显影微球的光学图片;Figure 3 is an optical picture of the developed microspheres provided in Example 2;
图4为实施例三提供的显影微球的光学图片;Figure 4 is an optical picture of the developed microspheres provided in Example 3;
图5为实施例四提供的显影微球的光学图片;Figure 5 is an optical picture of the developed microspheres provided in Example 4;
图6为实施例五提供的显影微球的光学图片; Figure 6 is an optical picture of the developed microspheres provided in Example 5;
图7为实施例六提供的显影微球的光学图片;Figure 7 is an optical picture of the developed microspheres provided in Example 6;
图8为实施例七提供的显影微球的光学图片;Figure 8 is an optical picture of the developed microspheres provided in Example 7;
图9为实施例八提供的显影微球的光学图片;Figure 9 is an optical picture of the developed microspheres provided in Example 8;
图10为实施例九提供的显影微球的光学图片;FIG10 is an optical image of the developed microspheres provided in Example 9;
图11为实施例十提供的显影微球的光学图片;Figure 11 is an optical picture of the developed microspheres provided in Example 10;
图12为实施例十一提供的显影微球的光学图片;Figure 12 is an optical picture of the developed microspheres provided in Example 11;
图13为实施例十二提供的显影微球的光学图片;Figure 13 is an optical picture of the developed microspheres provided in Embodiment 12;
图14为对比例一提供的显影微球的光学图片;Figure 14 is an optical picture of the developed microspheres provided in Comparative Example 1;
图15为对比例二提供的显影微球的光学图片。Figure 15 is an optical picture of the developed microspheres provided in Comparative Example 2.
具体实施方式Detailed ways
为使本申请实施例的目的、技术方案和优点更加清楚,下面对本申请的技术方案进行清楚、完整地描述。In order to make the purpose, technical solutions, and advantages of the embodiments of the present application clearer, the technical solutions of the present application are described clearly and completely below.
X射线显影化合物X-ray developing compounds
本申请中,X射线显影化合物的结构式如下:
In this application, the structural formula of the X-ray developing compound is as follows:
其中,n是1-5的整数。Among them, n is an integer from 1 to 5.
在上述技术方案中,I原子的作用是在X射线照射下显影,I原子的个数可以是1个、2个、3个、4个或5个。I原子的取代个数并不会导致显影剂与微球结合后的显影微球亲水性、悬浮性等差异。In the above technical solution, the function of I atoms is to develop under X-ray irradiation, and the number of I atoms can be 1, 2, 3, 4 or 5. The number of substitutions of I atoms will not cause differences in the hydrophilicity and suspension properties of the developing microspheres after the developer is combined with the microspheres.
在上述技术方案中,通过醚键连接碘代芳基与环氧基,形成X射线显影化合物,该显影化合物中的环氧基容易与聚乙烯醇微球中的羟基发生一步反应,以使聚乙烯醇微球具有显影功能,并且制备的显影微球亲水性较好。In the above technical solution, an iodoaryl group and an epoxy group are connected through an ether bond to form an Vinyl alcohol microspheres have a developing function, and the prepared developing microspheres are relatively hydrophilic.
在一些实施例中,X射线显影化合物的结构式可以为:
In some embodiments, the structural formula of the X-ray developing compound can be:
在另一些实施例中,X射线显影化合物的结构式还可以为:
In other embodiments, the structural formula of the X-ray imaging compound may also be:
X射线显影化合物的制备方法Method for preparing X-ray developing compound
上面介绍了X射线显影化合物的结构式以后,下面对X射线显影化合物的制备方法进行具体介绍,其通过反应式一提供的方法进行制备,反应式一如下:
After the structural formula of the X-ray developing compound is introduced above, the preparation method of the X-ray developing compound is introduced in detail below. It is prepared by the method provided by Reaction Formula 1. Reaction Formula 1 is as follows:
可选地,在绝氧环境中,将化合物II、化合物III、四丁基硫酸氢铵(2-20mol%)和四氢呋喃(THF)混合均匀形成溶液;在0-5℃的条件下加入40-60%(w/w)氢氧化钠或/和氢氧化钾溶液,反应20-40min后升至室温反应4-24h。Optionally, in an anaerobic environment, compound II, compound III, tetrabutylammonium hydrogen sulfate (2-20 mol%) and tetrahydrofuran (THF) are mixed uniformly to form a solution; 40-60% (w/w) sodium hydroxide or/and potassium hydroxide solution is added at 0-5°C, react for 20-40 minutes, then warm to room temperature and react for 4-24 hours.
例如:氮气保护下,在单口反应瓶中依次加入化合物II(1.0eq.)、化合物III(1.1eq.)、四丁基硫酸氢铵(2-20mol%)和THF,充分搅拌溶解。0-5℃下加入40-60%(w/w)氢氧化钠溶液,反应20-40min后升至室温反应4-24h。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得化合物I。For example: under nitrogen protection, add compound II (1.0eq.), compound III (1.1eq.), tetrabutylammonium hydrogen sulfate (2-20mol%) and THF in sequence to a single-mouth reaction bottle, stir and dissolve thoroughly. Add 40-60% (w/w) sodium hydroxide solution at 0-5°C, react for 20-40 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain compound I.
X射线显影微球X-ray imaging microspheres
该X射线显影微球的结构式如下:
The structural formula of the X-ray developing microsphere is as follows:
其中,n是1-5的整数。Among them, n is an integer from 1 to 5.
在上述技术方案中,该X射线显影微球的亲水性较好。In the above technical solution, the hydrophilicity of the X-ray developing microspheres is relatively good.
在一些实施例中,显影微球的结构式可以为:
In some embodiments, the structural formula of the developing microspheres can be:
在另一些实施例中,显影微球的结构式还可以为:
In other embodiments, the structural formula of the developing microspheres can also be:
X射线显影微球的制备方法Preparation method of X-ray developing microspheres
本申请中,在有机酸或有机碱的催化作用下,使上述X射线显影化合物的环氧基与聚乙烯醇微球上的至少部分羟基反应,以形成醚键结合。可以使X射线显影微球的制备较为简单,直接一步反应就可以使聚乙烯醇微球具有显影功能,同时,得到的显影微球的亲水性较好。In this application, under the catalytic action of an organic acid or an organic base, the epoxy group of the above-mentioned X-ray developing compound is reacted with at least part of the hydroxyl groups on the polyvinyl alcohol microspheres to form an ether bond. The preparation of X-ray developing microspheres can be relatively simple, and the polyvinyl alcohol microspheres can be given a developing function through a direct one-step reaction. At the same time, the obtained developing microspheres have good hydrophilicity.
其中,聚乙烯醇微球的制备方法为:聚乙烯醇与N-(2,2-二甲氧基乙基)-2-丙烯酰胺进行酸催化反应,得到N-(2,2-二甲氧基乙基)-2-丙烯酰胺接枝的大分子聚乙烯醇单体;将大分子聚乙烯醇单体与带磺酸基的水溶性单体、引发剂和水配制成水相,机械搅拌下将水相加入油相中,形成油包水的反相悬浮聚合体系;将此反相悬浮聚合体系升温至反应温度,加入催化剂进行悬浮聚合反应;反应得到聚乙烯醇微球,经净化、干燥过程后得到聚乙烯醇微球干球。The preparation method of polyvinyl alcohol microspheres is as follows: polyvinyl alcohol and N-(2,2-dimethoxyethyl)-2-acrylamide are subjected to an acid-catalyzed reaction to obtain a macromolecular polyvinyl alcohol monomer grafted with N-(2,2-dimethoxyethyl)-2-acrylamide; the macromolecular polyvinyl alcohol monomer is prepared with a water-soluble monomer with a sulfonic acid group, an initiator and water to form an aqueous phase, and the aqueous phase is added to the oil phase under mechanical stirring to form an oil-in-water reverse suspension polymerization system; the reverse suspension polymerization system is heated to a reaction temperature, and a catalyst is added to carry out a suspension polymerization reaction; polyvinyl alcohol microspheres are obtained by reaction, and polyvinyl alcohol microsphere dry balls are obtained after purification and drying processes.
可选地,将聚乙烯醇溶解在水中,然后加入N-(2,2-二甲氧基乙基)-2-丙烯酰胺,加入盐酸在室温下反应10h及以上,再使用氢氧化钠中和,得到大分子聚乙烯醇单体溶液。将醋酸丁酸纤维素溶解在乙酸丁酯中形成油相;将丙烯酰胺基-2-甲基丙磺酸钠盐溶于水中,加入大分子聚乙烯醇单体溶液和过硫酸钾形成水相。在搅拌条件下,将水相滴加至油相,滴加完毕后升温至50-60℃,加入四甲基乙二胺,反应7-9h。经过一系列纯化后干燥得到聚乙烯醇微球干球。Alternatively, dissolve polyvinyl alcohol in water, then add N-(2,2-dimethoxyethyl)-2-acrylamide, add hydrochloric acid and react at room temperature for 10 hours or more, and then use sodium hydroxide. and, a macromolecular polyvinyl alcohol monomer solution is obtained. Dissolve cellulose acetate butyrate in butyl acetate to form an oil phase; dissolve acrylamide-2-methylpropanesulfonic acid sodium salt in water, add macromolecular polyvinyl alcohol monomer solution and potassium persulfate to form a water phase . Under stirring conditions, add the water phase dropwise to the oil phase. After the addition is completed, raise the temperature to 50-60°C, add tetramethylethylenediamine, and react for 7-9 hours. After a series of purification and drying, dry polyvinyl alcohol microspheres are obtained.
在一些实施例中,催化剂为有机酸,制备方法包括:In some embodiments, the catalyst is an organic acid, and the preparation method comprises:
反应式二:
Reaction 2:
可选地,将聚乙烯醇微球干球、X射线显影化合物I和溶剂混合后加热溶胀,溶胀后加入有机酸,于40-90℃下反应24-48h。反应后清洗、除杂。Alternatively, dry polyvinyl alcohol microspheres, X-ray developing compound I and solvent are mixed and heated to swell. After swelling, organic acid is added and reacted at 40-90°C for 24-48 hours. After the reaction, clean and remove impurities.
其中,X射线显影化合物与聚乙烯醇微球的质量比为(1.5-3):1;X射线显影化合物与有机酸的质量比为1:(0.1-2)。有机酸为甲磺酸、三氟甲磺酸、对甲苯磺酸、三氟乙酸中的至少一种;溶剂为二甲基亚砜(DMSO)、N,N-二甲基甲酰胺(DMF)、N,N-二甲基乙酰胺、N-甲基吡咯烷酮(NMP)中的至少一种。Among them, the mass ratio of the X-ray developing compound and the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound and the organic acid is 1:(0.1-2). The organic acid is at least one of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and trifluoroacetic acid; the solvent is dimethyl sulfoxide (DMSO) or N,N-dimethylformamide (DMF). , at least one of N,N-dimethylacetamide and N-methylpyrrolidone (NMP).
作为示例性地,反应的温度为40℃、50℃、60℃、70℃、80℃或90℃;反应的时间为24h、28h、32h、36h、40h、44h或48h;X射线显影化合物与聚乙烯醇微球的质量比为1.5:1、2:1、2.5:1或3:1;X射线显影化合物与有机酸的质量比为1:0.1、1:0.5、1:1、1:1.5或1:2。 Illustratively, the reaction temperature is 40°C, 50°C, 60°C, 70°C, 80°C or 90°C; the reaction time is 24h, 28h, 32h, 36h, 40h, 44h or 48h; the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is 1.5:1, 2:1, 2.5:1 or 3:1; the mass ratio of the X-ray developing compound to the organic acid is 1:0.1, 1:0.5, 1:1, 1:1.5 or 1:2.
例如:将聚乙烯醇微球干球、X射线显影化合物I和DMSO混合后加热溶胀,溶胀后加入甲磺酸,于40-90℃反应24-48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸。For example: Mix dry polyvinyl alcohol microspheres, X-ray developing compound I and DMSO and heat to swell. After swelling, add methanesulfonic acid and react at 40-90°C for 24-48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid.
在另一些实施例中,催化剂为有机碱,所述制备方法包括:In other embodiments, the catalyst is an organic base, and the preparation method includes:
反应式三:
Reaction three:
可选地,将聚乙烯醇微球干球、X射线显影化合物I和溶剂混合后加热溶胀,溶胀后加入有机碱,于60-120℃下反应24-48h。反应后清洗、除杂。Optionally, polyvinyl alcohol microsphere dry balls, X-ray imaging compound I and solvent are mixed and heated to swell, and then an organic base is added after swelling, and the mixture is reacted at 60-120° C. for 24-48 hours. After the reaction, the mixture is washed and impurities are removed.
其中,X射线显影化合物与聚乙烯醇微球的质量比为(1.5-3):1;X射线显影化合物与有机碱的质量比为1:(0.5-3)。有机碱为三乙胺、二异丙基乙胺、1,8-二氮杂双环[5.4.0]十一碳-7-烯、1,4-二氮杂二环[2.2.2]辛烷中的至少一种;溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的至少一种。Among them, the mass ratio of the X-ray developing compound and the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound and the organic base is 1:(0.5-3). The organic bases are triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, and 1,4-diazabicyclo[2.2.2]octane At least one of alkane; the solvent is at least one of dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
作为示例性地,反应的温度为60℃、70℃、80℃、90℃、100℃、110℃或120℃;反应的时间为24h、28h、32h、36h、40h、44h或48h;X射线显影化合物与聚乙烯醇微球的质量比为1.5:1、2:1、2.5:1或3:1;X射线显影化合物与有机碱的质量比为1:0.5、1:1、1:1.5、1:2、1:2.5或1:3。Illustratively, the reaction temperature is 60°C, 70°C, 80°C, 90°C, 100°C, 110°C or 120°C; the reaction time is 24h, 28h, 32h, 36h, 40h, 44h or 48h; the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is 1.5:1, 2:1, 2.5:1 or 3:1; the mass ratio of the X-ray developing compound to the organic base is 1:0.5, 1:1, 1:1.5, 1:2, 1:2.5 or 1:3.
例如:将聚乙烯醇微球干球、X射线显影化合物I和DMSO混合后加热溶胀,溶胀后加入二异丙基乙胺,于60-120℃反应24-48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱。For example: Mix dry polyvinyl alcohol microspheres, X-ray developing compound I and DMSO and heat to swell. After swelling, add diisopropylethylamine and react at 60-120°C for 24-48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali.
基于上述的X射线显影化合物I,通过一步反应制备得到的X射线显影微球,且显影微球的亲水性较好。Based on the above-mentioned X-ray developing compound I, X-ray developing microspheres are prepared through a one-step reaction, and the developing microspheres have good hydrophilicity.
为使本申请实施例的目的、技术方案和优点更加清楚,下面将对本申请实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。In order to make the purpose, technical solutions, and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below. If the specific conditions are not specified in the examples, the conditions should be carried out according to the conventional conditions or the conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not indicated, they are all conventional products that can be purchased commercially.
实施例1:化合物I-1的合成
Example 1: Synthesis of Compound I-1
氮气保护下,在单口反应瓶中依次加入化合物II-1(20.6mmol,10g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30min后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-1(9.5g,85%),为浅黄色黏稠油状液体(纯度98%)。 Under nitrogen protection, compound II-1 (20.6mmol, 10g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-mouth reaction bottle. , stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-1 (9.5 g, 85%), which is a light yellow viscous oily liquid (purity 98%). .
将得到的目标产物I-1经HPLC(高效液相色谱),LCMS(液相质谱)和1H-NMR(核磁氢谱)表征。方法如下:The obtained target product I-1 was characterized by HPLC (high performance liquid chromatography), LCMS (liquid phase mass spectrometry) and 1 H-NMR (proton nuclear magnetic spectrum). Methods as below:
HPLC:测试仪器为安捷伦1260型高效液相色谱仪;色谱柱为十八烷基键合硅胶柱;流动相为0.1%磷酸水溶液和甲醇;检测器为VWD检测器;取0.1mg左右样品于样品瓶中,加DMSO溶解后直接进样检测;根据积分面积确定产品纯度。HPLC: The test instrument is an Agilent 1260 high-performance liquid chromatograph; the chromatographic column is an octadecyl-bonded silica gel column; the mobile phase is 0.1% phosphoric acid aqueous solution and methanol; the detector is a VWD detector; take about 0.1mg of the sample and put it on the sample In the bottle, add DMSO to dissolve and directly inject the sample for testing; determine the product purity based on the integrated area.
LCMS:测试仪器为安捷伦1260-6125型高效液相色谱质谱联用仪;色谱柱为十八烷基键合硅胶柱;流动相为0.1%甲酸水溶液和甲醇;检测器为质谱检测器;取0.1mg左右样品于样品瓶中,加DMSO溶解后直接进样检测,识别主要离子峰。LCMS: The test instrument is Agilent 1260-6125 high performance liquid chromatography mass spectrometer; the chromatographic column is an octadecyl bonded silica gel column; the mobile phase is 0.1% formic acid aqueous solution and methanol; the detector is a mass spectrometer detector; take 0.1 Put about mg sample into the sample bottle, add DMSO to dissolve it and directly inject the sample for detection to identify the main ion peaks.
1H-NMR:测试仪器为Bruker 400M核磁测试仪;采用探头为常温氢谱探头;取20-30mg样品加入核磁管中,加入0.3-0.5mL氘代氯仿溶解后测试。得到的目标产物I-1的核磁氢谱为:1H NMR(400MHz,CDCl3)δ8.07(d,J=2.1Hz,1H),7.84(d,J=2.1Hz,1H),4.65-4.56(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.65-2.63(m,1H);MS(ESI):m/z 543(M+H+)。 1 H-NMR: The test instrument is a Bruker 400M nuclear magnetic tester; the probe used is a normal temperature hydrogen spectrometer probe; add 20-30mg of the sample into the nuclear magnetic tube, add 0.3-0.5mL of deuterated chloroform to dissolve and test. The hydrogen nuclear magnetic spectrum of the obtained target product I-1 is: 1 H NMR (400MHz, CDCl 3 ) δ8.07 (d, J = 2.1 Hz, 1H), 7.84 (d, J = 2.1 Hz, 1H), 4.65- 4.56(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J= 4.7Hz, 1H), 2.65-2.63 (m, 1H); MS (ESI): m/z 543 (M+H + ).
实施例2:化合物I-2的合成
Example 2: Synthesis of Compound I-2
氮气保护下,在单口反应瓶中依次加入化合物II-2(20.6mmol,4.8g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30分钟后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-2(5.38g,90%),为浅黄色油状液体(纯度98%)。检测方法同实施例1,得到结果为:1H NMR(400MHz,CDCl3)δ7.39-7.26(m,4H),4.65-4.60(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.66-2.64(m,1H);MS(ESI):m/z 291(M+H+)。Under nitrogen protection, compound II-2 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-2 (5.38 g, 90%) as a light yellow oily liquid (purity 98%). The detection method is the same as in Example 1, and the results obtained are: 1 H NMR (400MHz, CDCl 3 ) δ7.39-7.26 (m, 4H), 4.65-4.60 (m, 2H), 3.82 (dd, J = 11.4, 3.0Hz ,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.66-2.64(m,1H);MS( ESI): m/z 291(M+H + ).
实施例3:化合物I-3的合成
Example 3: Synthesis of Compound I-3
氮气保护下,在单口反应瓶中依次加入化合物II-3(20.6mmol,4.8g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30分钟后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-3(5.44g,91%),为浅黄色油状液体(纯度98%)。检测方法同实施例1,得到结果为:1H NMR(400MHz,CDCl3)δ7.41-7.25(m,4H),4.64-4.53(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.66-2.63(m,1H);MS(ESI):m/z 291(M+H+)。Under nitrogen protection, compound II-3 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain target compound I-3 (5.44 g, 91%) as a light yellow oily liquid (purity 98%). The detection method is the same as in Example 1, and the results obtained are: 1 H NMR (400MHz, CDCl 3 ) δ7.41-7.25 (m, 4H), 4.64-4.53 (m, 2H), 3.82 (dd, J = 11.4, 3.0Hz ,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.66-2.63(m,1H);MS( ESI): m/z 291(M+H + ).
实施例4:化合物I-4的合成
Example 4: Synthesis of Compound I-4
氮气保护下,在单口反应瓶中依次加入化合物II-4(20.6mmol,4.8g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30分钟后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-4(5.68g,95%),为浅黄色油状液体(纯度98%)。检测方法同实施例1,得到结果为:1H NMR(400MHz,CDCl3)δ7.45(d,J=13.2Hz,2H),7.05(d,J=13.2Hz,2H),4.68(s,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H),2.66-2.63(m,1H);MS(ESI):m/z 291(M+H+)。Under nitrogen protection, compound II-4 (20.6mmol, 4.8g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to the single-neck reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-4 (5.68 g, 95%) as a light yellow oily liquid (purity 98%). The detection method is the same as in Example 1, and the results obtained are: 1 H NMR (400MHz, CDCl 3 ) δ7.45 (d, J = 13.2 Hz, 2H), 7.05 (d, J = 13.2 Hz, 2H), 4.68 (s, 2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.17(m,1H),2.82(t,J=4.7Hz,1H ), 2.66-2.63(m,1H); MS(ESI): m/z 291(M+H + ).
实施例5:化合物I-5的合成
Example 5: Synthesis of Compound I-5
氮气保护下,在单口反应瓶中依次加入化合物II-5(20.6mmol,7.4g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30分钟后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-5(5.44g,91%),为浅黄色油状液体(纯度98%)。检测方法同实施例1,得到结果为:1H NMR(400MHz,CDCl3)δ7.63(dd,J=11.2,3.2Hz,1H),7.45(dd,J=11.2,5.4Hz,1H),7.18(dd,J=5.4,3.2Hz,1H),4.64-7.55(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.18(m,1H),2.82(t,J=4.7Hz,1H),2.65-2.63(m,1H);MS(ESI):m/z 417(M+H+)。Under nitrogen protection, compound II-5 (20.6mmol, 7.4g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to a single-mouth reaction flask. ), stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-5 (5.44 g, 91%) as a light yellow oily liquid (purity 98%). The detection method is the same as Example 1, and the results obtained are: 1 H NMR (400MHz, CDCl 3 ) δ7.63 (dd, J = 11.2, 3.2 Hz, 1H), 7.45 (dd, J = 11.2, 5.4 Hz, 1H), 7.18(dd,J=5.4,3.2Hz,1H),4.64-7.55(m,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H) ,3.21-3.18(m,1H),2.82(t,J=4.7Hz,1H),2.65-2.63(m,1H); MS(ESI):m/z 417(M+H + ).
实施例6:化合物I-6的合成
Example 6: Synthesis of Compound I-6
氮气保护下,在单口反应瓶中依次加入化合物II-6(20.6mmol,10g)、化合物III(20.6mmol,1.6mL)、四丁基硫酸氢铵(1.0mmol,339.5mg)和THF(50mL),充分搅拌溶解。0℃下加入5mL 50%(w/w)氢氧化钠溶液,反应30分钟后升至室温反应4-24小时。TLC监控原料反应完全后,低温下减压旋干THF,加入无水乙醚和饱和氯化钠溶液。分液,有机相用饱和食盐水洗涤3次,无水硫酸钠干燥后过滤,减压旋干得目标化合物I-6(9.7g,87%),为浅黄色黏稠油状液体(纯度98%)。检测方法同实施例1,得到结果为:1H NMR(400MHz,CDCl3)δ8.03(s,2H),4.68(s,2H),3.82(dd,J=11.4,3.0Hz,1H),3.46(dd,J=11.4,5.9Hz,1H),3.21-3.18(m,1H),2.82(t,J=4.7Hz,1H),2.63-2.60(m,1H);MS(ESI):m/z 543(M+H+)。Under nitrogen protection, compound II-6 (20.6mmol, 10g), compound III (20.6mmol, 1.6mL), tetrabutylammonium hydrogen sulfate (1.0mmol, 339.5mg) and THF (50mL) were added in sequence to a single-mouth reaction bottle. , stir thoroughly to dissolve. Add 5 mL of 50% (w/w) sodium hydroxide solution at 0°C, react for 30 minutes, then rise to room temperature and react for 4-24 hours. After TLC monitors the complete reaction of the raw materials, spin THF to dryness under reduced pressure at low temperature, and add anhydrous ether and saturated sodium chloride solution. The liquids were separated, and the organic phase was washed three times with saturated brine, dried over anhydrous sodium sulfate, filtered, and spin-dried under reduced pressure to obtain the target compound I-6 (9.7g, 87%), which was a light yellow viscous oily liquid (purity 98%). . The detection method is the same as in Example 1, and the results obtained are: 1 H NMR (400MHz, CDCl 3 ) δ8.03 (s, 2H), 4.68 (s, 2H), 3.82 (dd, J = 11.4, 3.0Hz, 1H), 3.46(dd,J=11.4,5.9Hz,1H),3.21-3.18(m,1H),2.82(t,J=4.7Hz,1H),2.63-2.60(m,1H); MS(ESI):m /z 543(M+H + ).
实施组:PVA干球的制备: Implementation group: Preparation of PVA dry balls:
在装有顶置式机械搅拌250mL三口瓶中加入100mL纯化水,加入约15g的PVA(型号1888),升温至95℃溶解,降至室温;加入0.7654g的N-(2,2-二甲氧基乙基)-2-丙烯酰胺(NAAADA),随后加入10mL浓盐酸,反应在室温进行14小时,然后使用2.5M的氢氧化钠溶液中和至pH=7,得到大分子聚乙烯醇单体溶液。Add 100 mL of purified water to a 250 mL three-necked flask equipped with overhead mechanical stirring, add about 15 g of PVA (model 1888), heat to 95°C to dissolve, and lower to room temperature; add 0.7654 g of N-(2,2-dimethoxy ethyl)-2-acrylamide (NAAADA), then 10 mL of concentrated hydrochloric acid was added, the reaction was carried out at room temperature for 14 hours, and then neutralized to pH=7 with 2.5 M sodium hydroxide solution to obtain macromolecular polyvinyl alcohol monomer solution.
在装有顶置式机械搅拌1L三口瓶中加入600mL乙酸丁酯,加入18g醋酸丁酸纤维素溶解,得到油相;8.61g的丙烯酰胺基-2-甲基丙磺酸钠盐(AMPS钠)溶于60mL水中,加入160g大分子聚乙烯醇单体溶液,加入1.5g过硫酸钾,得到水相。Add 600 mL of butyl acetate to a 1L three-necked bottle equipped with overhead mechanical stirring, add 18g of cellulose acetate butyrate to dissolve, and obtain an oil phase; 8.61g of acrylamide-2-methylpropanesulfonate sodium salt (AMPS sodium) Dissolve in 60 mL of water, add 160 g of macromolecular polyvinyl alcohol monomer solution, and add 1.5 g of potassium persulfate to obtain a water phase.
转速设为400rpm,将水相滴加至油相中;滴加完毕后升温至55℃,加入2.2mL四甲基乙二胺,反应8h。经过一系列纯化后干燥得到原料干球。The speed was set to 400 rpm, and the aqueous phase was added dropwise to the oil phase; after the addition was completed, the temperature was raised to 55°C, 2.2 mL of tetramethylethylenediamine was added, and the reaction was continued for 8 hours. After a series of purifications and drying, the raw material dry ball was obtained.
实施例一:化合物I-1有机酸催化下制备显影微球
Example 1: Preparation of developing microspheres catalyzed by compound I-1 organic acid
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-1和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为632mg。取部分干球测量其干球碘含量为40.1%。计算其湿球碘含量为127mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-1 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 632 mg. Take some dry balls and measure the iodine content of the dry balls to be 40.1%. The calculated wet bulb iodine content is 127 mg/mL.
实施例二:化合物I-1有机碱催化下制备显影微球
Example 2: Preparation of developing microspheres catalyzed by compound I-1 organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-1和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为567mg。取部分干球测量其干球碘含量为30.1%。计算其湿球碘含量为85.3mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-1 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL of diisopropylethylamine, raise the temperature to 80°C, and react for 48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to constant weight, and weigh it to 567 mg. Take some dry balls and measure the iodine content of the dry balls to be 30.1%. The calculated wet bulb iodine content is 85.3 mg/mL.
实施例三:化合物I-2有机酸催化下制备显影微球
Example 3: Preparation of developing microspheres by organic acid catalysis of compound I-2
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-2和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为551mg。取部分干球测量其干球碘含量为15.1%。计算其湿球碘含量为41.6mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-2 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 551 mg. Take some dry balls and measure the iodine content of the dry balls to be 15.1%. The calculated wet bulb iodine content is 41.6 mg/mL.
实施例四:化合物I-2有机碱催化下制备显影微球
Example 4: Preparation of developing microspheres catalyzed by compound I-2 organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-2和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为502mg。取部分干球测量其干球碘含量为13.3%。计算其湿球碘含量为33.4mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-2 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL of diisopropylethylamine, raise the temperature to 80°C, and react for 48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 502 mg. Take some dry balls and measure the iodine content of the dry balls to be 13.3%. The calculated wet bulb iodine content is 33.4 mg/mL.
实施例五:化合物I-3有机酸催化下制备显影微球
Example 5: Preparation of developing microspheres catalyzed by compound I-3 under organic acid
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-3和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为535mg。取部分干球测量其干球碘含量为15.0%。计算其湿球碘含量为40.1mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-3 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 535 mg. Take some dry balls and measure the iodine content of the dry balls to be 15.0%. The calculated wet bulb iodine content is 40.1 mg/mL.
实施例六:化合物I-3有机碱催化下制备显影微球
Example 6: Preparation of developing microspheres catalyzed by compound I-3 organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-3和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为515mg。取部分干球测量其干球碘含量为14.1%。计算其湿球碘含量为36.3mg/mL。 Add 5g dry polyvinyl alcohol microspheres, 10g compound I-3 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C. . After swelling, add 5 mL of diisopropylethylamine, raise the temperature to 80°C, and react for 48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 515 mg. Take some dry balls and measure the iodine content of the dry balls to be 14.1%. The calculated wet bulb iodine content is 36.3 mg/mL.
实施例七:化合物I-4有机酸催化下制备显影微球
Example 7: Preparation of developing microspheres catalyzed by compound I-4 organic acid
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-4和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为530mg。取部分干球测量其干球碘含量为16.7%。计算其湿球碘含量为44.3mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-4 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to constant weight, and then weigh it to be 530 mg. Take some dry balls and measure the iodine content of the dry balls to be 16.7%. The calculated wet bulb iodine content is 44.3 mg/mL.
实施例八:化合物I-4有机碱催化下制备显影微球
Example 8: Preparation of developing microspheres catalyzed by compound I-4 organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-4和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为533mg。取部分干球测量其干球碘含量为13.7%。计算其湿球碘含量为36.5mg/mL。Add 5g polyvinyl alcohol microsphere dry ball, 10g compound I-4 and 125mL DMSO (dimethyl sulfoxide) to a three-necked flask with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat at 60℃ to swell. After swelling, add 5mL diisopropylethylamine and heat to 80℃ for 48h. After the reaction, wash the microspheres with DMSO, 10% sodium bicarbonate and water in turn to remove residual impurities and alkali to obtain developing microspheres. Take 2.0mL of wet bulbs, dry them with acetone, dry them at 105℃ for 5h to constant weight, and weigh them to be 533mg. Take part of the dry bulbs to measure the dry bulb iodine content, which is 13.7%. The wet bulb iodine content is calculated to be 36.5mg/mL.
实施例九:化合物I-5有机酸催化下制备显影微球
Example 9: Preparation of developing microspheres catalyzed by compound I-5 organic acid
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-5和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为618mg。取部分干球测量其干球碘含量为32.7%。计算其湿球碘含量为101mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-5 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight, and weigh it to 618 mg. Take some dry bulbs and measure the iodine content of the dry bulbs, which is 32.7%. The calculated wet bulb iodine content is 101mg/mL.
实施例十:化合物I-5有机碱催化下制备显影微球
Example 10: Preparation of developing microspheres catalyzed by compound I-5 under organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-5和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后 加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为603mg。取部分干球测量其干球碘含量为30.2%。计算其湿球碘含量为91.1mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-5 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C. . After swelling Add 5 mL of diisopropylethylamine, raise the temperature to 80°C and react for 48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 603 mg. Take some dry balls and measure the iodine content of the dry balls to be 30.2%. The calculated wet bulb iodine content is 91.1mg/mL.
实施例十一:化合物I-6有机酸催化下制备显影微球
Example 11: Preparation of developing microspheres catalyzed by compound I-6 organic acid
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-6和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL甲磺酸,保持60℃反应24h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和酸,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为698mg。取部分干球测量其干球碘含量为42.3%。计算其湿球碘含量为147.6mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-6 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL methanesulfonic acid and keep the reaction at 60°C for 24 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and acid to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 698 mg. Take some dry balls and measure the iodine content of the dry balls to be 42.3%. The calculated wet bulb iodine content is 147.6 mg/mL.
实施例十二:化合物I-6有机碱催化下制备显影微球
Example 12: Preparation of developing microspheres catalyzed by compound I-6 organic base
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球、10g化合物I-6和125mL DMSO(二甲基亚砜),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入5mL二异丙基乙胺,升温至80℃反应48h。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为652mg。取部分干球测量其干球碘含量为40.7%。计算其湿球碘含量为132.7mg/mL。Add 5g dry polyvinyl alcohol microspheres, 10g compound I-6 and 125mL DMSO (dimethyl sulfoxide) into a three-necked flask equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C . After swelling, add 5 mL of diisopropylethylamine, raise the temperature to 80°C, and react for 48 hours. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, and then dry it at 105°C for 5 hours to a constant weight and then weigh it to be 652 mg. Take some dry balls and measure the iodine content of the dry balls to be 40.7%. The calculated wet bulb iodine content is 132.7mg/mL.
对比例一:显影微球的制备
Comparative Example 1: Preparation of developing microspheres
氮气保护下,在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球和300mL NMP(N-甲基吡咯烷酮),调节搅拌转速为100rpm/min,于60℃加热溶胀。溶胀后加入10g研碎的NaOH,混合搅拌10分钟。加入100g 2,3,5-三碘苄溴,反应48h后降至室温。反应后将微球依次用NMP、DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为425mg。取部分干球测量其干球碘含量为10.7%。计算其湿球碘含量为22.7mg/mL。实验显示采用专利CN102781974B描述工艺,得到的显影微球碘含量低,且微球体积膨胀,反应过程中微球结构被部分破坏。由于2,3,5-三碘苄溴优先在微球表面反 应,使表面亲水性变差,反应试剂难于到达微球内部,干球碘含量偏低。由于微球结构部分破坏,微球体积膨胀,一定体积微球的干重降低,致使湿球碘含量偏低。Under nitrogen protection, add 5g dry polyvinyl alcohol microspheres and 300mL NMP (N-methylpyrrolidone) into a three-necked flask with a mechanical stirring paddle on the top, adjust the stirring speed to 100rpm/min, and heat and swell at 60°C. After swelling, add 10g of ground NaOH and mix for 10 minutes. Add 100g of 2,3,5-triiodobenzyl bromide and react for 48 hours before cooling to room temperature. After the reaction, the microspheres were washed with NMP, DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight, and weigh it to 425 mg. Take some dry balls and measure the iodine content of the dry balls to be 10.7%. The calculated wet bulb iodine content is 22.7 mg/mL. Experiments show that using the process described in patent CN102781974B, the developed microspheres obtained have low iodine content, the volume of the microspheres expands, and the microsphere structure is partially destroyed during the reaction process. Since 2,3,5-triiodobenzyl bromide preferentially reacts on the surface of microspheres, The reaction will make the surface hydrophilicity worse, it will be difficult for the reaction reagent to reach the inside of the microsphere, and the iodine content of the dry sphere will be low. Due to the partial destruction of the microsphere structure, the volume of the microspheres expands, and the dry weight of the microspheres of a certain volume decreases, resulting in a low wet bulb iodine content.
对比例二:显影微球的制备
Comparative Example 2: Preparation of developing microspheres
在顶端装有机械搅拌桨的三口瓶中加入5g聚乙烯醇微球干球和50mL纯化水,调节搅拌转速为100rpm/min,于90℃加热溶胀。溶胀后加入11g环氧丙烷和0.25g NaOH催化剂,于70℃反应,将反应液缓慢滴加到盛有甲醇沉淀剂的烧杯中,边滴加边用玻璃棒搅拌,PVA微球再用甲醇反复抽滤洗涤三次后放于50~60℃下干燥至恒重,得到活化聚乙烯醇微球。Add 5g dry polyvinyl alcohol microspheres and 50mL purified water to a three-necked bottle equipped with a mechanical stirring paddle at the top, adjust the stirring speed to 100rpm/min, and heat and swell at 90°C. After swelling, add 11g propylene oxide and 0.25g NaOH catalyst and react at 70°C. Slowly add the reaction solution dropwise into the beaker containing methanol precipitant. Stir with a glass rod while adding dropwise. PVA microspheres are then repeatedly filled with methanol. Filter and wash with suction three times and then dry at 50-60°C until constant weight to obtain activated polyvinyl alcohol microspheres.
在氮气流下,将得到的活化聚乙烯醇溶解于50ml无水NMP。在130℃下将反应混合物搅拌5分钟;然后使温度降至50℃。添加55g 2,3,5-三碘苄基醇(0.113mol),并搅拌反应混合物10分钟。然后,在10分钟内添加0.05g磨碎并干燥的NaOH。在4小时之后,降至室温。反应后将微球依次用DMSO、10%碳酸氢钠和水洗涤,除去残留的杂质和碱,得到显影微球。实验发现,制得的微球表面形貌较差,大量微球粘连在一起,无法分开。取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量为512mg。取部分干球测量其干球碘含量为17.3%。计算其湿球碘含量为44.3mg/mL。由于微球的表面变差和粘连,致使2,3,5-三碘苄醇难以到达微球内部,碘含量偏低。Under nitrogen flow, the obtained activated polyvinyl alcohol was dissolved in 50 ml of anhydrous NMP. The reaction mixture was stirred at 130°C for 5 minutes; then the temperature was allowed to drop to 50°C. 55 g of 2,3,5-triiodobenzyl alcohol (0.113 mol) were added and the reaction mixture was stirred for 10 minutes. Then, 0.05 g of ground and dried NaOH was added over 10 minutes. After 4 hours, cool to room temperature. After the reaction, the microspheres were washed with DMSO, 10% sodium bicarbonate and water in sequence to remove residual impurities and alkali to obtain developed microspheres. Experiments found that the surface morphology of the prepared microspheres was poor, and a large number of microspheres were stuck together and could not be separated. Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to a constant weight and then weigh it to be 512 mg. Take some dry balls and measure the iodine content of the dry balls to be 17.3%. The calculated wet bulb iodine content is 44.3 mg/mL. Due to the surface deterioration and adhesion of the microspheres, it is difficult for 2,3,5-triiodobenzyl alcohol to reach the interior of the microspheres, and the iodine content is low.
图1为本申请实施组提供的聚乙烯醇湿球的光学图片;图2为实施例一提供的显影微球的光学图片;图3为实施例二提供的显影微球的光学图片;图4为实施例三提供的显影微球的光学图片;图5为实施例四提供的显影微球的光学图片;图6为实施例五提供的显影微球的光学图片;图7为实施例六提供的显影微球的光学图片;图8为实施例七提供的显影微球的光学图片;图9为实施例八提供的显影微球的光学图片;图10为实施例九提供的显影微球的光学图片;图11为实施例十提供的显影微球的光学图片;图12为实施例十一提供的显影微球的光学图片;图13为实施例十二提供的显影微球的光学图片。从图1以及图2-图13可以看出,聚乙烯醇微球湿球的形貌良好,经过显影修饰以后,得到的产品为形貌良好,亲水性良好的球形。Figure 1 is an optical picture of the polyvinyl alcohol wet ball provided by the implementation group of this application; Figure 2 is an optical picture of the developed microsphere provided in Example 1; Figure 3 is an optical picture of the developed microsphere provided in Example 2; Figure 4 Figure 5 is an optical picture of the developed microspheres provided in Example 3; Figure 5 is an optical picture of the developed microspheres provided in Embodiment 4; Figure 6 is an optical picture of the developed microspheres provided in Embodiment 5; Figure 7 is provided in Embodiment 6 Optical pictures of the developed microspheres; Figure 8 is an optical picture of the developed microspheres provided in Embodiment 7; Figure 9 is an optical picture of the developed microspheres provided in Embodiment 8; Figure 10 is an optical picture of the developed microspheres provided in Embodiment 9 Optical pictures; Figure 11 is an optical picture of the developed microspheres provided in Embodiment 10; Figure 12 is an optical picture of the developed microspheres provided in Embodiment 11; Figure 13 is an optical picture of the developed microspheres provided in Embodiment 12. It can be seen from Figure 1 and Figure 2 to Figure 13 that the morphology of the polyvinyl alcohol microsphere wet sphere is good. After development and modification, the obtained product is a spherical shape with good morphology and good hydrophilicity.
图14为对比例一提供的显影微球的光学图片。从图14可以看出,对比例一提供的微球体积膨胀、破坏。图15为对比例二提供的显影微球的光学图片。从图15可以看出,对比例二提供的微球形貌差,大量粘连。Figure 14 is an optical picture of the developed microspheres provided in Comparative Example 1. It can be seen from Figure 14 that the microspheres provided in Comparative Example 1 expanded in volume and were destroyed. Figure 15 is an optical picture of the developed microspheres provided in Comparative Example 2. As can be seen from Figure 15, the microspheres provided in Comparative Example 2 have poor morphology and a large number of adhesions.
检测实施例一-实施例十二以及对比例一和对比例二提供的显影微球的性能进行检测,测试结果如表1,其测试方法如下:Test the performance of the developing microspheres provided in Examples 1 to 12 and Comparative Examples 1 and 2. The test results are as shown in Table 1, and the test method is as follows:
取2.0mL湿球,用丙酮干燥后,105℃下烘干5h至恒重后称量其重量。取部分干球测量其干球碘含量。Take a 2.0 mL wet bulb, dry it with acetone, dry it at 105°C for 5 hours to constant weight and weigh it. Take some dry bulbs and measure the iodine content of the dry bulbs.
称取约5mg样品于无尘灰纸上,按照《中国药典》第二部操作,吸收液为:10mL 5g/L氢氧化钠与10mL 1%维生素C,急速通氧1min,用表面皿覆盖瓶口,静置10min,点燃包有样品的滤纸尾部,迅速将瓶塞插入燃烧瓶中,按紧瓶塞,并用少量水封闭瓶口,燃烧完毕后(应无灰色、黑色碎片或颗粒,若燃烧后留有应无灰色、黑色碎片或颗粒,表示供试品燃烧不完全,遇此情况应重新取样燃烧),立即充分振摇,使生成的烟雾完全吸入吸收液中,放置15min,开启瓶塞,用少量水冲洗瓶塞及铂丝,合并洗液及吸收 液,同时同法做空白实验。加入3滴署红指示剂,用0.01mol/L硝酸银标准滴定液滴定,记录消耗体积,平行操作两次。Weigh about 5 mg of the sample on dust-free paper, and operate according to the second part of the "Chinese Pharmacopoeia". The absorption solution is: 10 mL 5 g/L sodium hydroxide and 10 mL 1% vitamin C. Rapidly oxygenate for 1 minute, and cover the bottle with a watch glass. mouth, let it stand for 10 minutes, ignite the tail of the filter paper wrapped with the sample, quickly insert the stopper into the combustion bottle, press the stopper tightly, and seal the bottle mouth with a small amount of water. After burning (there should be no gray or black fragments or particles, if after burning There should be no gray or black fragments or particles left, which means the test sample is not completely burned. In this case, resample and burn). Shake immediately and fully to make the generated smoke completely inhaled into the absorbing liquid. Leave it for 15 minutes and open the cork. Rinse the bottle stopper and platinum wire with a small amount of water, combine the washing liquid and absorb liquid, and at the same time do a blank experiment in the same way. Add 3 drops of signature red indicator, titrate with 0.01mol/L silver nitrate standard titrant, record the consumed volume, and operate twice in parallel.
计算:
X=(C×V×127×M湿球)/(M×V湿球)×100%
calculate:
X = (C × V × 127 × M wet bulb ) / (M × V wet bulb ) × 100%
X:为样品中碘含量;X: iodine content in the sample;
C:为硝酸银浓度,mol/L;C: is the concentration of silver nitrate, mol/L;
V:为硝酸银消耗体积,mL;V: is the consumption volume of silver nitrate, mL;
M:为样品质量,mg;M: is the sample mass, mg;
M(湿球):为湿球质量,mg;M (wet bulb): is the wet bulb mass, mg;
V(湿球):为湿球体积,mL;V (wet bulb): is the wet bulb volume, mL;
127:为碘的相对分子质量。127: is the relative molecular mass of iodine.
湿球碘含量计算公式如下:
湿球碘含量=(微球干重×干球碘含量)/湿球体积
The formula for calculating wet bulb iodine content is as follows:
Wet bulb iodine content = (microsphere dry weight × dry bulb iodine content)/wet bulb volume
HU值测试方法:将各实施例显影微球进行Micro CT测试,对根据上面方法制备的显影微球样品的不透射线性进行评估。在Nunc冻存管小瓶中将珠粒悬浮于0.5%琼脂糖凝胶,使用装备有钨阳极的微型CT成像系统扫描器,利用微计算机断层扫描技术(微型CT成像系统),对显影微球的不透射线性进行测试。然后将图像分割从孔隙结构中分离出聚合物以便报告聚合物辐射密度。然后,使用在同一天得到的水标准品计算以HU为单位的辐射密度。HU value test method: The developing microspheres of each example were subjected to Micro CT testing, and the radiopacity of the developing microsphere samples prepared according to the above method was evaluated. Beads were suspended in 0.5% agarose gel in Nunc cryovial vials, and the micro-CT imaging system scanner equipped with a tungsten anode was used to develop micro-computed tomography (micro-CT imaging system). Radiopacity was tested. The images were then segmented to separate the polymer from the pore structure in order to report the polymer radiation density. The radiation density in HU was then calculated using water standards obtained on the same day.
表1显影微球的性能
Table 1 Properties of the developed microspheres
从表1可以看出,在有机酸或有机碱的催化作用下,本申请提供的X射线显影化合物,均可以通过一步反应使聚乙烯醇微球具有显影功能。且使用有机酸作为催化剂,得到的显影微球的碘含量更高,HU值也更高,显影能力更强。As can be seen from Table 1, under the catalytic action of organic acids or organic bases, the X-ray developing compounds provided in this application can all make polyvinyl alcohol microspheres have a developing function through a one-step reaction. And by using organic acids as catalysts, the developed microspheres obtained have higher iodine content, higher HU value, and stronger developing ability.
以上所描述的实施例是本申请一部分实施例,而不是全部的实施例。本申请的实施例的详细描述并非旨在限制要求保护的本申请的范围,而是仅仅表示本申请的选定实施例。基于本申请中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本申请保护的范围。 The above-described embodiments are part of the embodiments of the present application, but not all of the embodiments. The detailed description of the embodiments of the application is not intended to limit the scope of the application as claimed, but rather to represent selected embodiments of the application. Based on the embodiments in this application, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of this application.

Claims (10)

  1. 一种X射线显影化合物,其特征在于,所述X射线显影化合物的结构式如下:
    An X-ray developing compound, characterized in that the structural formula of the X-ray developing compound is as follows:
    其中,n是1-5的整数。Among them, n is an integer from 1 to 5.
  2. 根据权利要求1所述的X射线显影化合物,其特征在于,所述X射线显影化合物的结构式为:
    The X-ray developing compound according to claim 1, wherein the structural formula of the X-ray developing compound is:
  3. 一种权利要求1或2所述的X射线显影化合物的制备方法,其特征在于,包括:A method for preparing an X-ray developing compound according to claim 1 or 2, characterized in that it includes:
    反应式一:
    Reaction 1:
  4. 一种X射线显影微球,其特征在于,所述显影微球的结构式如下:
    An X-ray developing microsphere, characterized in that the structural formula of the developing microsphere is as follows:
    其中,n是1-5的整数。Among them, n is an integer from 1 to 5.
  5. 根据权利要求4所述的X射线显影微球,其特征在于,所述显影微球的结构式如下:
    The X-ray developing microsphere according to claim 4, characterized in that the structural formula of the developing microsphere is as follows:
  6. 一种X射线显影微球的制备方法,其特征在于,包括:在有机酸或有机碱的催化作用下,使权利要求1或2所述的X射线显影化合物的环氧基与聚乙烯醇微球上的至少部分羟基反应,以形成醚键结合。A method for preparing X-ray developing microspheres, characterized in that it comprises: reacting the epoxy group of the X-ray developing compound according to claim 1 or 2 with at least part of the hydroxyl groups on the polyvinyl alcohol microspheres under the catalytic action of an organic acid or an organic base to form an ether bond.
  7. 根据权利要求6所述的制备方法,其特征在于,催化剂为有机酸,所述制备方法包括:The preparation method according to claim 6, characterized in that the catalyst is an organic acid, and the preparation method includes:
    反应式二:
    Reaction 2:
  8. 根据权利要求7所述的制备方法,其特征在于,所述X射线显影化合物与所述聚乙烯醇微球的质量比为(1.5-3):1;所述X射线显影化合物与所述有机酸的质量比为1:(0.1-2);The preparation method according to claim 7, characterized in that the mass ratio of the X-ray developing compound and the polyvinyl alcohol microsphere is (1.5-3):1; the mass ratio of the X-ray developing compound and the organic The mass ratio of acids is 1:(0.1-2);
    或/和,所述有机酸为甲磺酸、三氟甲磺酸、对甲苯磺酸、三氟乙酸中的至少一种;所述溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的至少一种。 Or/and, the organic acid is at least one of methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and trifluoroacetic acid; the solvent is dimethyl sulfoxide, N,N-dimethyl At least one of formamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
  9. 根据权利要求6所述的制备方法,其特征在于,催化剂为有机碱,所述制备方法包括:The preparation method according to claim 6, characterized in that the catalyst is an organic base, and the preparation method includes:
    反应式三:
    Reaction three:
  10. 根据权利要求9所述的制备方法,其特征在于,所述X射线显影化合物与所述聚乙烯醇微球的质量比为(1.5-3):1;所述X射线显影化合物与所述有机碱的质量比为1:(0.5-3);The preparation method according to claim 9, characterized in that the mass ratio of the X-ray developing compound to the polyvinyl alcohol microspheres is (1.5-3):1; the mass ratio of the X-ray developing compound to the organic base is 1:(0.5-3);
    或/和,所述有机碱为三乙胺、二异丙基乙胺、1,8-二氮杂双环[5.4.0]十一碳-7-烯、1,4-二氮杂二环[2.2.2]辛烷中的至少一种;所述溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的至少一种。 Or/and, the organic base is triethylamine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diazabicyclo [2.2.2] At least one of octane; the solvent is dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone. At least one.
PCT/CN2023/109266 2022-09-22 2023-07-26 X-ray developing compound and preparation method therefor, and x-ray developing microsphere and preparation method therefor WO2024060825A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202211159438.5A CN115590984B (en) 2022-09-22 2022-09-22 X-ray developing compound and preparation method thereof, and X-ray developing microsphere and preparation method thereof
CN202211159438.5 2022-09-22

Publications (1)

Publication Number Publication Date
WO2024060825A1 true WO2024060825A1 (en) 2024-03-28

Family

ID=84845625

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/109266 WO2024060825A1 (en) 2022-09-22 2023-07-26 X-ray developing compound and preparation method therefor, and x-ray developing microsphere and preparation method therefor

Country Status (2)

Country Link
CN (1) CN115590984B (en)
WO (1) WO2024060825A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115590984B (en) * 2022-09-22 2023-07-14 科睿驰(深圳)医疗科技发展有限公司 X-ray developing compound and preparation method thereof, and X-ray developing microsphere and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102781974A (en) * 2010-03-10 2012-11-14 克劳德伯纳德里昂第一大学 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
CN114259599A (en) * 2021-12-30 2022-04-01 上海汇禾医疗科技有限公司 Iodine complexing polyvinyl alcohol embolism microsphere capable of X-ray developing and preparation method thereof
CN114805644A (en) * 2022-06-24 2022-07-29 苏州美创医疗科技有限公司 Nontransmissive polymer and preparation method and application thereof
CN115590984A (en) * 2022-09-22 2023-01-13 科睿驰(深圳)医疗科技发展有限公司(Cn) X-ray developing compound and preparation method thereof, and X-ray developing microsphere and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114146190B (en) * 2021-12-30 2024-01-26 科睿驰(深圳)医疗科技发展有限公司 High-suspension developing microsphere and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102781974A (en) * 2010-03-10 2012-11-14 克劳德伯纳德里昂第一大学 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
CN114259599A (en) * 2021-12-30 2022-04-01 上海汇禾医疗科技有限公司 Iodine complexing polyvinyl alcohol embolism microsphere capable of X-ray developing and preparation method thereof
CN114805644A (en) * 2022-06-24 2022-07-29 苏州美创医疗科技有限公司 Nontransmissive polymer and preparation method and application thereof
CN115590984A (en) * 2022-09-22 2023-01-13 科睿驰(深圳)医疗科技发展有限公司(Cn) X-ray developing compound and preparation method thereof, and X-ray developing microsphere and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REDDY, M. N. ET AL.: "Dual catalysis by Cu(I): facile single step click and intramolecular C–O bond formation leading to triazole tethered dihydrobenzodioxines/benzoxazines/ benzoxathiines/benzodioxepines", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 11, no. 42, 14 November 2013 (2013-11-14), XP055919815, ISSN: 1477-0520, DOI: 10.1039/c3ob41332b *

Also Published As

Publication number Publication date
CN115590984A (en) 2023-01-13
CN115590984B (en) 2023-07-14

Similar Documents

Publication Publication Date Title
WO2024060825A1 (en) X-ray developing compound and preparation method therefor, and x-ray developing microsphere and preparation method therefor
CN114146190B (en) High-suspension developing microsphere and preparation method thereof
CN114262279B (en) X-ray developable molecule, embolism microsphere and preparation method thereof
CN111024673B (en) Ratiometric fluorescent molecularly imprinted polymer and preparation method and application thereof
CN106268703B (en) DNA immunization adsorbent and preparation method thereof
JP2009242770A (en) Porous cellulose gel, method for producing the same and use thereof
CN106478974A (en) A kind of PVA grafting bonding polystyrene divinylbenzene crosslinked microsphere hydrophilic modification method
CN111019022B (en) Sulfonic acid functionalized polystyrene high-fluorescence microsphere and preparation method thereof
JP6073608B2 (en) Chromatographic separation agent
CN114057600B (en) X-ray developable molecule, drug-loaded embolism microsphere and preparation method thereof
JPH0616809A (en) Alkylated polyethyleneimine derivative and its production
CN109320636B (en) Triple stimulus-responsive core-crosslinked polymer micelle and preparation method and application thereof
CN115490639B (en) X-ray developing compound and preparation method thereof, and X-ray developing embolic material and preparation method thereof
CN116251226A (en) Radiopaque development embolism microsphere and preparation method thereof
CN116253815A (en) Radiopaque plug microsphere and preparation method and application thereof
CN110305301B (en) Amphiphilic dendritic sugar-containing copolymer and synthesis method thereof
JPH0348897B2 (en)
CN110117345A (en) A kind of vesica pharmaceutical carrier discharging process visualization
CN116239489A (en) Amide compound containing iodinated aryl or iodinated heteroaryl, and preparation method and application thereof
Bachmann et al. Purification of porphyrin esters by gel filtration
RU2094117C1 (en) Sorbent and method for its production
JPH04156952A (en) Cation exchange resin and separation of hemoglobin by using this resin
JP3987627B2 (en) Method for producing filler for cation exchange chromatography and measuring method using the filler
AU2021431510A1 (en) Crosslinked poly(allylamine) polymer pharmaceutical compositions
JPH0118052B2 (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23867120

Country of ref document: EP

Kind code of ref document: A1